Chinese pharmaceutical company, Fosun Pharma, on Tuesday, donated anti-malaria drugs to Kenya’s Health Ministry to boost the war against the tropical disease.
Malaria remains the leading cause of death among pregnant women and children below five years in the country.
Rashid Aman, Chief Administrative Secretary in Kenya’s Ministry of Health, said the donation will aid treatment of severe cases.
“The drug that is being donated is Artesunate injection 60 mg for the treatment of severe malaria, a life-threatening condition,’’ Aman said during COVID-19 briefing in Nairobi.
Aman said the company is a World Health Organisation (WHO) qualified manufacturer of anti-malaria drugs.
He said the donation consists of 400,000 vials of the injectable drug valued at 73 million shillings (about $670,000).
“This quantity of drug can treat about 70,000 patients with severe malaria.
“They will go a long way in helping us to buffer our stocks for people with severe malaria,’’ said Aman.
He said that Kenya’s public hospitals in 2019 treated 250,000 cases of severe malaria with artesunate and 75 per cent were children below 15 years.
Aman said the government has put some measures in place to ensure that malaria prevention and treatment programmes are not disrupted by the COVID-19 pandemic.